Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Compliance rate versus behavioral factors among the study participants in Kabo area, southwestern Ethiopia, 2012

From: Predictors of compliance with community-directed treatment with ivermectin for onchocerciasis control in Kabo area, southwestern Ethiopia

Variables (N = 308) Category (no.) Compliance with Ivermectin P-value
   Yes (%) No (%)  
Know (heard about) the disease onchocerciasis Yes (294) 244 (83.0) 50 (17.0) 0.00
No (14) 5 (35.7) 9 (64.3)  
Know the vector (Black fly) for transmission Yes (26) 22 (84.6) 4 (15.4) 0.61
No (282) 227 (80.5) 55 (19.5)  
Know mode of transmission (Black fly bite) Yes (24) 19 (79.2) 5 (20.8) 0.83
No (284) 230 (81.0) 54 (19.0)  
Know sing and symptoms (at least one) Yes (227) 188 (82.8) 39 (17.2) 0.82
No (81) 61 (75.3) 20 (24.7)  
The responsible body for distributing the drug CDDs (237) 212 (89.5) 25 (10.5) 0.00
HEWs (36) 20 (55.6) 16 (44.4)  
Health professionals (20) 10 (50.0) 10 (50.0)  
Others (15) 7 (46.7) 8 (53.3)  
Know any CDD in their village Yes (251) 224 (89.2) 27 (10.8) 0.01
No (57) 25 (43.9) 32 (56.1)  
Know how CDDs recruited Yes (121) 101 (83.5) 20 (16.5) 0.35
No (168) 148 (79.1) 20 (20.9)  
Attend village meeting on CDTI at least once Yes (174) 144 (82.8) 30 (17.2) 0.33
No (134) 105 (78.4) 29 (21.6)  
Onchocerciasis a serious disease Yes (260) 237(91.2) 23(8.8) 0.00
No (33) 10(30.3) 23(69.7)  
Onchocerciasis common in their village Yes (243) 225 (92.6) 18(7.4) 0.00
No (47) 22 (46.8) 25 (53.2)  
Risk perception to onchocerciasis Yes at risk (252) 222(88.1) 30(11.9) 0.00
Not at risk (34) 16 (27.6) 18 (72.4)  
Perceived performance of CDDs Good (217) 191(88.0) 26 (12.0) 0.00
Poor (91) 58 (63.7) 33 (36.3)  
Perceived importance of CDTI As very important (281) 246(81.7) 55 (18.3) 0.01
As obligation (27) 3 (42.9) 4 (57.1)  
Perception towards the program (can control onchocerciasis) Yes (274) 244(89.1) 30(10.9) 0.00
No (3) 1(33.3) 2(66.7)  
Know a person who stopped treatment Yes (16) 9(56.2) 7 (43.8) 0.01
No (292) 240 (82.2) 52 (17.8)  
Perceived reason of stopping the treatment Sever effect of the drug 2 (40.0) 3 (60.0) 0.53
Lack of good case mgt. 5 (71.4) 2 (28.6)  
Others 2 (50.0) 2 (50.0)